Global X Fds genomic biotech shares owned by Morgan Stanley
Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Global X Fds genomic biotech
Tip: Access up to 7 years of quarterly data
All positions including Global X Fds genomic biotech held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Global X Fds genomic biotech by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $86k | 10k | 8.43 |
| 2024-12-31 | $101k | 10k | 9.71 |
| 2024-09-30 | $128k | 11k | 11.25 |
| 2024-06-30 | $138k | 13k | 10.44 |
| 2024-03-31 | $154k | 14k | 11.38 |
| 2023-12-31 | $145k | 13k | 11.56 |
| 2023-09-30 | $128k | 13k | 10.17 |
| 2023-06-30 | $156k | 13k | 12.12 |
| 2022-12-31 | $49k | 3.8k | 12.65 |
| 2022-06-30 | $139k | 11k | 12.13 |
| 2022-03-31 | $173k | 11k | 15.08 |
| 2021-06-30 | $295k | 12k | 24.79 |
| 2020-12-31 | $95k | 4.0k | 23.51 |
| 2020-09-30 | $6.0k | 325 | 18.46 |
Top funds holding Global X Fds genomic biotech
View all funds holding Global X Fds genomic biotech